16th Annual International Ultmann Chicago Lymphoma Symposium
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers. Next year’s program offered in 2019 represents the 16th IUCLS.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. The format of the meeting includes a combination of expert presentations, interactive case discussions, poster/abstract presentations, and an opportunity for question-and-answer debates. The IUCLS is a two-day meeting held Friday afternoon and Saturday morning and early afternoon. Friday afternoon concentrates on the scientific and translational aspects of lymphoma, while Saturday has a clinical focus.
Learn more at the symposium website!
At the conclusion of this educational activity, participants will be able to:
- Distinguish between the different treatment approaches for newly diagnosed T-cell lymphoma and mantle cell lymphoma;
- Discuss the role of allogeneic stem cell transplant in Hodgkin lymphoma treatment;
- Identify patient characteristics best suited for CAR T-cell treatment;
- Differentiate between the different lymphoma staging and re-staging classifications to develop an appropriate patient treatment plan;
- Evaluate the different treatment options for follicular lymphoma and the risk of transformation to other cancers;
- State key environmental and genetics risks for lymphoma and the roles they play in lymphoid malignancies;
- Outline key molecular and cytogenetic information in order to determine best treatment options for chronic lymphocytic leukemia;
- Determine short and long-term toxicities of cardiotoxic agents used in lymphoma treatment;
- Describe how epigenetic targets in lymphoid cancers can be used to improve patient outcomes;
- List non-chemotherapy options for follicular lymphoma.
SPECIAL ATTENDEE RATES AVAILABLE!
- Room Rates: $209+ USD per night; Grand Tower
- Check-in: 3:00PM CT, Check-out: 11:00AM CT
- Phone: Please call the hotel at 800-628-2112 and identify yourself as part of the Chicago Lymphoma Symposium 2019 or reference booking code F93.
- Online: Should you prefer, you can also book online by clicking the button below.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-834-3730 or via email at email@example.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Elwood V. Jensen Professor of Medicine
Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
Professor of Medicine
Division of Hematology/Oncology
Feinberg School of Medicine
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 13.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This live activity is designated for a maximum of 13.50 continuing nursing education units.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
- BOTH the Symposium (Friday afternoon and Saturday) and the Friday morning Nursing Session
- ONLY the Symposium (Friday afternoon and Saturday)
- ONLY the Friday morning Nursing Session
Apply the early bird code to recieve the early bird rate! Early bird expires March 12, 2019.
Early Bird Code
|Profession Type||Early Bird||Early Bird Code||Regular Registration|
|Profession Type||Early Bird||Early Bird Code||Regular Registraton|